Video·3 min read·May 2026

Understanding PMS Through the Lens of Inflammation: New Insights and Solutions

Cold Therapy • 3 min read • Based on research by Jorge Lolas-Talhami, Juana Lafaja-Mazuecos, Diego Ferrández-Sempere (2015)

For many women, the days leading up to their menstrual cycle can bring a wave of discomfort, emotional turbulence, and physical distress. This phenomenon, known as Premenstrual Syndrome (PMS), affects a significant portion of the population and can disrupt daily life in profound ways. If you have experienced debilitating symptoms such as anxiety, fatigue, or severe pelvic pain, you are not alone.

Recent research sheds light on the potential underlying causes of PMS, suggesting that inflammation may play a critical role. Understanding this connection opens the door to innovative treatment options that move beyond traditional methods, providing hope for those seeking relief.

The Inflammatory Connection to PMS

A study conducted by Lolas-Talhami and colleagues in 2015 explored the possibility that PMS might stem from an inflammatory response within the uterus. By examining the medical records of 161 women suffering from severe PMS, the researchers uncovered a significant reduction in symptoms following a combination of targeted cryotherapy and local antibiotic treatments.

Before treatment, the average severity of PMS symptoms was high, with women rating their discomfort around 4 out of 5. Remarkably, after the treatment, this average dropped to just 0.5. This substantial shift suggests that addressing inflammation could be key to alleviating PMS symptoms.

The Power of Cryotherapy

During the study, cryotherapy—exposing the body to cold temperatures—was combined with antibiotic and anti-inflammatory injections. The results were compelling: participants reported an 86.4% reduction in depression and a 90.7% decrease in anxiety after treatment. These outcomes indicate that cold exposure can have a direct and positive impact on both emotional and physical symptoms of PMS.

By reducing inflammation, cryotherapy may help restore a sense of equilibrium, allowing women to navigate their cycles with greater ease. The mean duration of severe symptoms before treatment was nearly thirteen days; after treatment, this duration shrank to about two and a half days. This change reflects the potential of cryotherapy as a powerful tool in the pursuit of resilience and well-being.

Practical Implications and Future Directions

While the findings of this study are promising, further research is necessary to validate the efficacy and safety of cryotherapy as a treatment for PMS. However, the implications for women experiencing severe symptoms are noteworthy. As we continue to explore the relationship between inflammation and PMS, it becomes increasingly clear that new protocols can emerge, offering sanctuary from the often overwhelming effects of this condition.

For those seeking relief from PMS, considering treatments that address underlying inflammation may be a beneficial approach. This knowledge empowers women to advocate for themselves and explore innovative therapies that extend beyond traditional medications.

Key Takeaways

Inflammation may be a significant factor in the severity of PMS symptoms, suggesting new avenues for treatment.
Cryotherapy combined with antibiotic and anti-inflammatory treatments has shown promising results, reducing symptom severity and duration.
Further research is needed, but understanding the inflammatory nature of PMS can empower women to seek effective, evidence-based solutions.

Based on: Is Premenstrual Syndrome a Uterine Inflammatory Disease? Retrospective Evaluation of an Etiologic Approach
Jorge Lolas-Talhami, Juana Lafaja-Mazuecos, Diego Ferrández-Sempere (2015). Open Journal of Obstetrics and Gynecology

Contrast Collective • Science-backed wellness

Wim's Wise Words

A second take, from someone who's lived it.

🧊 Wim's Wise Words

Is Premenstrual Syndrome a Uterine Inflammatory Disease Retrospective

The Core Claim

This paper asks a question that sounds almost too simple: what if PMS isn't primarily a hormonal problem? What if it's inflammatory? Lolas-Talhami and colleagues spent decades treating severe PMS with a protocol that had nothing to do with ovulation suppression or serotonin — they were injecting antibiotics and anti-inflammatories directly into the cervical stroma, then applying localized cryotherapy. The results across 148 women were striking: mean symptom severity dropped from roughly 4 out of 5 to 0.5. Anxiety reduced by 90.7 percent. Depression by 86.4 percent. The average duration of severe symptoms collapsed from nearly thirteen days per cycle to two and a half.

That's not a marginal improvement. That's a near-complete resolution of symptoms through a mechanism that conventional gynecology barely considers.

Where This Fits in the Inflammation Picture

Throughout this knowledge base, one theme keeps surfacing: the body's inflammatory cascade is more central to symptom generation than we typically appreciate. We see it in cardiovascular disease, in neurodegeneration, in depression, in metabolic dysfunction. The research on cold exposure consistently shows that one of the most reliable downstream effects of thermal stress is a reduction in pro-inflammatory cytokines — IL-6 drops, C-reactive protein falls, the inflammatory signal quiets.

What Lolas-Talhami is proposing is that the uterus, responding to infectious or traumatic insults over time — delivery, surgery, even sexual activity — develops a chronic low-grade inflammatory state. The luteal phase, with its immune modulation to protect potential implantation, allows that inflammation to amplify. The result: a cascade of symptoms that look hormonal but are actually inflammatory in origin.

The body doesn't distinguish between inflammation in the brain and inflammation in the uterus. It speaks one language: signal. Change the signal, change the symptoms.

Where the Science Gets Complicated

To be honest, this research sits at the edge of mainstream gynecology. The hormonal model of PMS — progesterone sensitivity, serotonin deficiency, estrogen fluctuation — has decades of literature behind it. The inflammatory hypothesis is newer, less replicated, and this study is retrospective with no control group. Lolas-Talhami himself worked with over 1,600 patients over decades, which is extraordinary dedication to a hypothesis, but it also means the selection effects are significant.

What makes me take it seriously is the consistency of the response across all ten symptom categories. When you see anxiety, depression, fatigue, pelvic pain, and bloating all improving by 80 to 90 percent through the same intervention, that pattern suggests you've hit something foundational — not a placebo effect, not a statistical artifact.

The Practical Takeaway

If you or someone you know has severe PMS that hasn't responded to standard treatments, this paper is worth bringing to a gynecologist who understands pelvic inflammatory conditions. The treatment protocol here isn't DIY-accessible — it requires clinical expertise. But the underlying principle matters: anti-inflammatory approaches to PMS are underexplored and potentially transformative.

In the meantime, the lifestyle interventions that consistently reduce systemic inflammation — regular contrast therapy, sleep quality, anti-inflammatory nutrition — are reasonable adjuncts worth discussing with a physician.

The Surprising Connection

Here's what stopped me in the paper: during the cryotherapy freezing periods, actively symptomatic patients reported "peaceful and deep well-being feelings" that reversed during defrosting. The authors called this the "control rods effect" — a nuclear reactor analogy for cold dampening a runaway inflammatory response. We see something parallel in the whole-body cold exposure literature: the rapid norepinephrine release from cold contact has genuine anti-inflammatory and mood-stabilizing effects. The mechanism may differ from cervical cryotherapy, but the principle rhymes. Cold quiets the signal. It's a tool worth understanding deeply.

Is Premenstrual Syndrome a Uterine Inflammatory Disease Retrospective

Understanding PMS Through the Lens of Inflammation: New Insights and Solutions

The Inflammatory Connection to PMS

The Power of Cryotherapy

Practical Implications and Future Directions

Key Takeaways

Related articles

Cryotherapy for the prevention of weekly paclitaxel-induced peripheral

Methodology of Cryotherapy Use in Medical Practice

Whole-body cryotherapy as adjunct treatment of depressive and anxiety